title: Systemic affects of methamphetamine use.
abstract: Methamphetamine (meth) is the most widely used illegal stimulant in the United States and is especially prevalent in Midwestern states. The sense of euphoria caused by the drug, the ease of manufacturing and the relatively low cost make it a drug of choice for many. The broad range of systemic effects potentially caused by the use of this drug is wide reaching and can vary in degree and presentation from patient to patient. Abnormalities include cardiac and pulmonary disorders as well as observable integumentary problems, psychoses, CNS disturbances, problems associated with immunity and constitutional signs and symptoms. Health care providers need to be vigilant in their efforts to identify patients who may be users of meth and to identify any subtle abnormal findings that may be indicative of significant underlying systemic pathology. Questionnaires like the RAFFT (Relax, Alone, Forget, Friends, Trouble) and the MINI (Mini-International Neuropsychiatric Interview) can be helpful in identifying substance abuse disorders in patients.
authors.affiliation: Department of Physical Therapy, University of South Dakota School of Health Sciences, USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Hauer
mesh_terms: D019969:Amphetamine-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000633:toxicity*; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D006801:Humans; D008403:Mass Screening; D008694:Methamphetamine / Q000633:toxicity*; D012307:Risk Factors; D013023:South Dakota; D014481:United States
chemical_list: D000697:Central Nervous System Stimulants; D008694:Methamphetamine